Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3346/jkms.2020.35.e174 http://scihub22266oqcxt.onion/10.3346/jkms.2020.35.e174 32383370!7211515!32383370     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Korean+Med+Sci 2020 ; 35 (18): e174 Nephropedia Template TP {{tp|p=32383370|t=2020. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients |pdf=|usr=}}{{32383370}} gab.com Text Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients JO: J Korean Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=32383370 #FOAvip Initially, acute loss of smell (anosmia) and taste (ageusia) was not considered important symptoms for coronavirus disease 2019 (COVID-19). To determine the prevalence of these symptoms and to evaluate their diagnostic significance, we (approximately 150 physicians of the Daegu Medical Association) prospectively collected data of cases of anosmia and ageusia from March 8, 2020, via telephone interview among 3,191 patients in Daegu, Korea. Acute anosmia or ageusia was observed in 15.3% (488/3,191) patients in the early stage of COVID-19 and in 15.7% (367/2,342) patients with asymptomatic-to-mild disease severity. Their prevalence was significantly more common among females and younger individuals (P = 0.01 and P < 0.001, respectively). Most patients with anosmia or ageusia recovered within 3 weeks. The median time to recovery was 7 days for both symptoms. Anosmia and ageusia seem to be part of important symptoms and clues for the diagnosis of COVID-19, particularly in the early stage of the disease. Twit Text FOAVip Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients ????J Korean Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=32383370 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32383370 #FOAvip English Wikipedia <ref>{{Cite pmid|32383370}}</ref> Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients #MMPMID32383370 Lee Y; Min P; Lee S; Kim SW J Korean Med Sci 2020[May]; 35 (18): e174 PMID32383370show ga Initially, acute loss of smell (anosmia) and taste (ageusia) was not considered important symptoms for coronavirus disease 2019 (COVID-19). To determine the prevalence of these symptoms and to evaluate their diagnostic significance, we (approximately 150 physicians of the Daegu Medical Association) prospectively collected data of cases of anosmia and ageusia from March 8, 2020, via telephone interview among 3,191 patients in Daegu, Korea. Acute anosmia or ageusia was observed in 15.3% (488/3,191) patients in the early stage of COVID-19 and in 15.7% (367/2,342) patients with asymptomatic-to-mild disease severity. Their prevalence was significantly more common among females and younger individuals (P = 0.01 and P < 0.001, respectively). Most patients with anosmia or ageusia recovered within 3 weeks. The median time to recovery was 7 days for both symptoms. Anosmia and ageusia seem to be part of important symptoms and clues for the diagnosis of COVID-19, particularly in the early stage of the disease. |*Coronavirus/genetics/isolation & purification[MESH] |*Pandemics[MESH] |Adult[MESH] |Age Distribution[MESH] |Ageusia/epidemiology/*etiology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Clinical Laboratory Techniques[MESH] |Coronavirus Infections/*complications/diagnosis/epidemiology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Olfaction Disorders/epidemiology/*etiology[MESH] |Pneumonia, Viral/*complications/epidemiology[MESH] |Polymerase Chain Reaction[MESH] |Prevalence[MESH] |Republic of Korea/epidemiology[MESH] |SARS-CoV-2[MESH] |Sex Distribution[MESH] |Smell[MESH]Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Pa(epmc).pdf DeepDyve Pubget Overpricing